Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein

Journal of Experimental Medicine

Volumn 186, Issue 6, 1997, Pages 867-876

  Prabhu Das, Mercy ^a   Nicholson, Lindsay B ^a   Greer, Judith M ^b   Kuchroo, Vijay K ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CLONE CELLS; CROSS REACTIONS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; PHENOTYPE; TH1 CELLS; TH2 CELLS;

EID: 0007179779     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.6.867     Document Type: Article

References (33)

1. Pettinelli, C.B., and D.E. McFarlin. 1981. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Ly1+2- lymphocytes. J. Immunol. 127: 1420-1423.
2. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
3. Waldor, M.K., S.S. Hardy, R. Herzenberg, L.A. Herzenberg, L. Lanier, M. Lim, and L. Steinman. 1985. Reversal of experimental allergic encephalomyelitis with a monoclonal antibody to a T cell subset marker (L3T4). Science (Wash. DC). 227:415-417.
4. Brostoff, S.W., and D.W. Mason. 1984. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol. 133:1938-1942.
5. Ben-Nun, A., and I. Cohen. 1982. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of line and characterization of the cells. J. Immunol. 129:303-308.
6. Kuchroo, V.K., R.A. Sobel, J.C. Laning, C.A. Martin, E. Greenfield, M.E. Dorf, and M.B. Lees. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific-for a synthetic peptide of myelin proteolipid protein. J. Immunol. 148:3776-3782.
7. Mosmann, T.R., and R.L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
8. Mosmann, T.R., and R.L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111-147.
9. Heinzel, F.P., M.D. Sadick, B.J. Holaday, R.L. Coffinan, and R.M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
10. Salagame, P., J.S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R.L. Modlin, and B.R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (Wash. DC). 254:279-282.
11. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
12. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway. 1993. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
13. Kuchroo, V.K., C.A. Martin, J.M. Greer, S.T. Ju, R.A. Sobel, and M.E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371-4382.
14. Khoruts, A., S.D. Miller, and M.K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyclitis induced by effector Th1 cells. J. Immunol. 155:5011-5017.
15. Kuchroo, V.K., M. Prabhu Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
16. Nicholson, L.B., and V.K. Kuchroo. 1996. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:837-842.
17. Kuchroo, V.K., J.M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R.A. Sobel, and M.B. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326-3336.
18. Franco, A., S. Southwood, T. Arrhenius, V.K. Kuchroo, H.M. Grey, A. Sette, and G.Y. Ishioka. 1994. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24:940-946.
19. McRae, B.L., K. Nikcevich, S. Hurst and S.D. Miller. 1995. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells. J. Neuroimmunol. 60:17-28.
20. van der Veen, R.C., P. Chen, and M. McMillan. 1995. Myelin proteolipid protein-induced Th1 and Th2 clones express TCR with similar fine specificity for peptide and CDR3 homology despite diverse Vβ usage. Cell. Immunol. 166:291-295.
21. Nicholson, L.B., J.M. Greer, R.A. Sobel, M.A. Lees, and V.K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents experimental autoimmune encephalomyelitis. Immunity. 3:397-405.
22. Kuchroo, V.K., J.K. Steele, R.M. O'Hara, S. Jayaraman, P. Selvaraj, E. Greenfield, R.T. Kubo, and M.E. Dorf. 1990. Relationships between antigen specific helper and inducer suppressor T cell hybridomas. J. Immunol. 145:438-448.
23. O'Garra, A., and K. Murphy 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6: 458-466.
24. Janeway, C.A., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
25. + T cells. J. Exp. Med. 182:1591-1596.
26. + T helper cell phenotype development in a T cell receptor-transgenic model. J. Exp. Med. 182:1579-1584.
27. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses and cytokines. Cell. 76:241-251.
28. Fowell, D., A.J. McKnight, F. Powrie, R. Dyke, and D. Mason. 1991. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123: 37-64.
29. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569-1574.
30. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D.J. Mitchell, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (Lond.). 379: 343-346.
31. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science (Wash. DC). 268:1185-1188.
32. Pakala, S.V., M.O. Kurrer, and J.D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299-306.
33. Lafaille, J.J., F. Van de Keere, A.L. Hsu, J.L. Baron, W. Haas, C.S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease. J. Exp. Med. 186:307-312.